On Monday, the US Food and Drug Administration convened an expert panel to discuss the use and safety of selective serotonergic reuptake inhibitors ...
admin
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social ...
A chronic form of eczema that develops specifically in the hands now has its first approved FDA-approved drug, a topical cream from dermatological ...
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data ...
It could be years before a cell therapy from Nkarta reaches autoimmune disease patients in the market, but CEO Paul Hastings still thinks about the ...
Last week, the Congressional Budget Office (CBO) released a report titled “How Changes to Funding for the NIH and Changes in the FDA’s Review Times ...
The FDA has announced plans to eliminate or propose eliminating Standards of Identity (“SOIs”) for 52 food items, stating that many of these regulations ...
Sarepta Therapeutics’ report of a second fatality this year in a patient dosed with its Duchenne muscular dystrophy gene therapy raised the ...
Health and Human Services Secretary Robert F. Kennedy Jr. has been throwing a fit over Food and Drug Administration regulators for years. Setting ...
For the third time this year, a patient treated with a Sarepta Therapeutics gene therapy has died, a revelation that comes as the company tries to ...
Dr. Mark A. Scialdone, a recognized expert in the field of organic chemistry who specializes in natural product chemistry, is an inventor of 37 ...
In a set of astonishing identical Director Review decisions, the Acting USPTO Director discretionarily denied five IPR petitions whose ...
